
Why We Live Today In An Age Of Value Creation
Despite dire newspaper headlines, the fact is, we live today in an age of extraordinary, sustained value creation. New ways of creating value have enabled fast-growing enterprises of all sizes in most sectors and in many countries to create unprecedented new value in dynamic workplaces with continuous innovation. These enterprises have already transformed the world economy. This is not a theory: it's a fact. It's not something that needs to be invented. It's already happened.
Meanwhile, autocrats, grifters and self-interested firms still trying to extract value operate behind smokescreens of worthwhile purposes and experience no more than spasmodic growth, with generally low levels of staff engagement and little if any real innovation.
Why don't all businesses realize that they would do much better if they embraced value creation?
Some 25 years ago, humanity began a major change. It occurred when some businesses started to think differently. They asked themselves: 'What if instead of aiming to make money, we set out to create value for customers? It's so much easier to make contact with customers with the internet and customers already have much more power than before. So why not accept this and give them what they want and need?'
The impact was magic. It happened so rapidly it's hard to recall how dramatically we chose to live differently. Very quickly, with the help of these businesses, we transformed how we work, how we communicate, how we get about, how we shop, how we manufacture things, how we bank, how we receive health care, how we get educated, how we raise our children, how we play and watch games, how we entertain ourselves, how we read, how we listen to music, how we watch theater and movies, how we engage with nature, how we understand history, how we worship; in short, how we live. The transition was accelerated by the COVID pandemic that began in 2020.
When firms aimed consistently at value creation, something else remarkable happened: they found that they made much more money than firms that aimed at making money. Not just more money: They made exponentially more money,
And their workplaces were generally more engaging because staff believed in creating value for customers.
At first, it was just technology firms. But pretty soon, it was occurring in almost all sectors and many countries: Retail, agriculture, manufacturing, pharmaceuticals, finance, even fashion.
Firms of all sizes: big, medium and even tiny firms.
So now perhaps 20% of public firms are focused on creating value for customers.
What about the other 80% of firms still focused on making money and extracting value for themselves? Why don't they embrace creating value when it would make them so much more money?
In the industrial era of the 20th century, management thinking reflected an internal view of the firm. Management was about making the firm operate more efficiently and effectively within a relatively stable world, with given systems, processes, and practices. The firm did what it could for the customer within the constraints of its existing systems. Top management knew best and issued directives to the rest of the organization, using steep chains of command to ensure order. Car companies competed against other car companies, banks with other banks, and so on. Managers saw themselves as solving the equivalent of familiar jigsaw puzzles. If they could fit the pieces together into the correct pattern, they could extract, and take, the value they believed to be their due.
Value creation requires different thinking. The perspective is mainly external. Success depends less on the internal workings of the firm and more on its ability to master a turbulent unpredictable world of exponential technological possibilities and to delight unpredictable customers. Competition can come from anywhere. Innovation is pivotal and involves not merely improving what already exists, but creating what is new. Firms aspire to generate new possibilities of working, operating, interacting, playing, and living for its customers. In the process, the firm can create new experiences for them, just as artists create works of art. Staff, partners, and sometimes customers, are active in the creative process. The firm is not merely copying or learning known rules. Profits are emergent effects of invention and creation. They are the results of making rather than taking, often out of literally nothing but the imagination.
When the product itself is digital, firms can grow quickly and attain global reach within a few years. In the industrial era, such scope usually took decades. In digital firms, many of the dis-economies of scale—the difficulties that came from being big—have tended to disappear. Instead, global scale—and the firm being the best in the world at what it does—can become almost mandatory. From Scarcity To Abundance
In the digital age, radically different business models have become possible and even necessary: from markets to platforms; from ownership to access, from workers to co-creators of value, from sellers and buyers to providers and users.
Firms that mastered the requirements of the new age have benefited from what economists call network effects. Users get more value as other users join the network, both as an increase in value to all other users and as an encouragement of non-users to join the network.
Whereas the industrial era was largely based on scarcity, digital services are based on abundance. Exponential technologies can generate an almost infinite array of digital services. It has become possible to make instant contact and converse with anyone from anywhere, buy anything anywhere, access the entire world's information, listen to almost any piece of the world's music, take, share and view unlimited photographs, and create and stream videos, all at zero, or a near-zero cost. The winning firms are those that have found ways to deliver, and monetize, parts of this blizzard of possibilities. The Emergence Of Deep Purpose
The dynamic of industrial-era management was all about the brain—measuring and calculating every possible metric, analyzing the past for clues to the future, and studying ratios and relationships. The passion, if any, concerned being rational. Shows of emotion were almost verboten . At most, there was talk of mindset. The heart supposedly had no role.
In the 21st century, the heart became exposed. Pervasive access to digital information collapsed the distinction between public and private content, and leaders could no longer hide behind press releases. Casual remarks made in private could become headline news. In the low-trust context, unflattering narratives—both true and false—became pervasive in social media. Some leaders began to see that they needed to present themselves and their firms as they are and express honestly what they believe. There has been a growing recognition that the whole person—including the heart—is key to leadership in this emerging world.
Building trust in companies and their leaders isn't easy, given many decades of dissembling. Commerce had become the antithesis of the authentic. Moreover, inside the firm, rah-rah HR workshops compounded the offense by attempting to manipulate the staff's very sense of self, getting them to profess feelings that they had never felt. Fixing The Flaws Of The Digital Winners
At the same time, we learned that digital technology can also have potentially devastating negative effects. It can be used to create tighter and more minute monitoring and control than even the worst tyrant, while invading without permission every nook and cranny of individuals' private lives, and turning human connections into zombie-like interactions, as customers and employees find themselves dealing with robotic machines or AI rather than people.
Some actors became very wealthy very rapidly, while those less able to adapt fell by the wayside. In a winner-take-most world, big firms grow steadily bigger and are tempted to exploit their dominance. In due course, the winners can be demonized, while the losers exercise political pressure to prevent change and redress their own suffering. These phenomena—familiar to business historians—are now playing out and are frequently—and mistakenly—seen as unprecedented.
The lessons of history can be helpful. The rapid accumulation wealth is not necessarily a sign of wrongdoing. Yet the abuse of newly-acquired power is common and must be addressed. Regulations designed for different technologies need to be rethought so as to encourage benefits for everyone while limiting winners' inevitable missteps. Self-regulation by winners to resist the temptation to crush every competitor must be part of the solution.
Current bipartisan efforts to regulate big technology firms have assumed a strident tone. These phenomena are common in the transition from one technology to another. The challenge is to understand the facts underlying the claims and counter claims, find ways to depoliticize decision-making, and implement effective regulation. Transitioning To The Age of Value Creation
Transitioning from traditional management to the age of value creation involves changes in the way people speak, think, feel, act, and interact with their fellow human beings. It cannot be absorbed by traditional conferences with 'sages on stage', panels of speakers debating the changes, or reading an article or a book.
It is mainly learned from encountering the experiences of other practitioners either through live interactions or through narratives. There is a need to learn from practitioners who have lived and practiced the change and learned what worked and what didn't in their context. Yet outsiders can't tell participants what would work in new contexts. Businesses themselves have to discover what the new way of thinking, speaking, feeling, acting and interacting might mean for their own workplace and their own business.
And read also:
Revolutionizing Business: From Management To Value Creation
How Creating Value For Others Has Become The Key To Business Success Appendix 1: Self-interested Organizations and Value Creating Enterprises
Summary of prevalent differences between self-interested vs value creating firms Stephen Denning Appendix 2: Firms with a track record of sustained fast growth
Appendix 2: Firms with a track record of sustained fast growth and engaged workplaces Stephen Denning; Seeking Alpha
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Workers union announces tentative agreement with King Soopers after days of negotiations
The union that represents thousands of Colorado King Soopers employees announced on Thursday it had reached a tentative agreement on a three-year contract with the company after days of negotiations.

Yahoo
20 minutes ago
- Yahoo
Federal Court in Massachusetts Denies Vivo Capital's Petition for Relief on SINOVAC
Court denies Vivo Capital's petition for relief relating to shareholder votes and corporate governance, clearing another legal hurdle for distribution of the US$55.00 per common share special cash dividend Marks fourth unsuccessful legal attempt in deceptive and disparaging campaign by Advantech/Prime or Vivo Capital against current Board and its Chairman New reports from two leading independent proxy advisory firms, Glass Lewis and ISS, firmly recommend shareholders vote to KEEP the current Board chaired by Dr. Chiang Li BEIJING, July 07, 2025--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that on June 30, the United States District Court for the District of Massachusetts denied Vivo Capital's petition against 1Globe Capital LLC ("1Globe") for relief relating to SINOVAC's shareholder votes and corporate governance. In its ruling, the Court concluded, "relief relating to governance outcomes or shareholder votes – are DENIED without prejudice." The Massachusetts ruling marks the fourth unsuccessful legal attempt by either Advantech/Prime Success ("Advantech/Prime") or Vivo Capital (together "the Dissenting Investor Group") to strip SINOVAC common shareholders of their rightful dividend payments. This result follows Advantech/Prime's recently failed petition in New York and Advantech/Prime and Vivo Capital's recently failed petition in Hong Kong – which were repeated attempts to block or delay a hearing for interim relief sought by the Company et al at the Antiguan High Court and to interfere with the Company's payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board. The Dissenting Investor Group continues to interfere with the current Board's fiduciary duties to implement the UK Privy Council's unappealable ruling in January 2025. In this ruling, the UK Privy Council deemed the former illegitimate board an "Imposter Board" and handed 1Globe – the investment arm of a cancer-focused global R&D group and SINOVAC's largest shareholder – a victory on all grounds. In addition, the UK Privy Council Judicial Committee, comprising five UK Supreme Court Justices, concluded that there was "nothing unlawful in the conduct of 1Globe" in connection with SINOVAC's 2018 AGM. The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy is crystal clear: (1) block actions taken by the SINOVAC Board to distribute rightful dividend payments to valid SINOVAC common shareholders; (2) protect the ill-gotten gains it stripped from SINOVAC subsidiaries over the past seven years; and (3) regain control of SINOVAC in order to continue to loot the Company. Having failed in the courtroom, the Dissenting Investor Group has decided to instead use deceptive and false stories to attack 1Globe and its founder Dr. Chiang Li, who chairs the current SINOVAC Board. As noted in SINOVAC's proxy materials, Dr. Li is an accomplished clinician, scientist, inventor, entrepreneur and a seasoned executive with international recognitions. Dr. Li and 1Globe have successfully challenged the Dissenting Investor Group's abuse in court for the past seven years and championed the rights and interests of all valid SINOVAC shareholders. During those seven years, The Dissenting Investor Group, in coordination with the former illegitimate board (the "Imposter Former Board"), pursued the following schemes: Privatization attempt at a below-market price in 2016, which would have succeeded had it not been for the efforts of 1Globe (who declined an invite by the Former Management Buyout Group to join and profit from its privatization attempt); Invalid PIPE transaction at a below-market price in 2018, which materially diluted SINOVAC shareholders and was made at a time when the Company did not need the capital; Commitment by the Imposter Former Board to invest ~US$139 million of SINOVAC cash into a venture fund managed by Vivo Capital – creating a clear conflict of interest. This would be in addition to the approximately US$100 million SINOVAC has already invested into Vivo Capital funds. US$15 million debt investment into Sinovac Life Sciences Co., Ltd. ("SLS"), a wholly owned subsidiary of SINOVAC, in exchange for a 15% equity interest in SLS in 2020, at a time when the Company did not need the capital and which has resulted in over US$1 billion of distributions made to the Dissenting Investor Group. In contrast, SINOVAC common shareholders have received no dividends and haven't been able to trade their shares for the past six years. To add insult to injury, the Imposter Former Board publicly stated in April 2024 in the Company's 2023 20-F that it had "no plan to pay any cash dividends on SINOVAC Antigua's shares in the foreseeable future"; Barrage of baseless and wasteful legal action in 2025, after refusing to accept the Privy Council's non-appealable ruling, with the goal of interfering with the dividend payment unless the Dissenting Investor Group is able to double dip on dividends already received from SLS; Deceptive and disparaging campaign against current SINOVAC board members that is meant to intimidate them and interfere with the stability and function of the current Board. The Dissenting Investor Group's hostile actions, baseless claims and wasteful litigation are evidence that it poses a direct threat to the value of your investment and the future of SINOVAC. Don't let the Dissenting Investor Group, which is working in coordination with SAIF and is represented on SAIF's Reconstituted Imposter Former Board, regain control of the Company. If the Reconstituted Imposter Former Board succeeds, it will put all valid shareholders' future dividend payments at risk – this includes the current Board's announced plans for an additional US$11.00 per common share cash dividend, contingent on the cancellation of the unauthorized PIPE shares, and its adopted policy to issue regular dividends out of surplus cash. The current SINOVAC Board remains committed to its mission of restoring fairness, delivering value, and protecting the rights of all valid shareholders. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card "AGAINST" Proposal 1 to remove the current Board and "AGAINST" Proposal 2 to appoint the Reconstituted Imposter Former Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at SinovacSpecialMeeting@ About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ("SEC") and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at ir@ Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. View source version on Contacts Investor and Media Contact FGS GlobalSinovac@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
24 minutes ago
- Bloomberg
Trump Threatens 10% Tariff for Nations Aligned With BRICS
By Good morning. Donald Trump dials up trade tensions. China imposes curbs on EU medical devices in a retaliatory move. And Tesla shares may come under pressure on Elon Musk's political plans. Listen to the day's top stories. Donald Trump said any country aligning with the 'anti-American' policies of the BRICS nations will face an additional 10% levy. The group of countries that includes Brazil, Russia, India, China and South Africa met over the weekend and condemned US and Israeli attacks on Iran. Trump also said tariff letters will be delivered from noon Washington time today. US Treasury Secretary Scott Bessent indicated some countries may be given an extension to finalize agreements.